Please provide your email address to receive an email when new articles are posted on . The AGA formulated 11 conditional recommendations to inform the use of biomarkers in the management of Crohn’s ...

This prospective study in a large cohort of patients examined the use of calprotectin measurement in feces as a diagnostic test to identify clinically significant gastrointestinal findings in patients ...

Although not currently recommended as a formal therapeutic target in ulcerative colitis (UC) management, histologic healing is associated with improved long-term clinical outcomes. In a small ...

Children with cystic fibrosis had lower key fecal SCFAs, distinct diets, and butyrate linked to inflammation markers.

Share on Pinterest Blood tests could be used more in the future in Crohn’s disease management. Bisual Studio/Stocksy More than half a million people in the United States live with Crohn’s disease. New ...

FC, Calprotectin; FL, Lactoferrin; MPO, Myeloperoxidase; CRP, C-reactive-protein; ESR, Erythrocyte sedimentation rate; ST2, Suppression of tumorigenicity 2, TNFAIP6 ...

New AGA clinical practice guidelines highlight the role of noninvasive biomarkers, including fecal calprotectin, fecal lactoferrin and C-reactive protein, for the management of patients with ...

New research suggests that simple tests may help predict when a chronic bowel disease is about to worsen.

SAN DIEGO, July 14, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho") and BÜHLMANN Laboratories AG today announced the availability of the BÜHLMANN fCAL turbo and fPELA turbo ...

Regular stool tests already used in NHS care, combined with dietary information, could help identify people with inflammatory bowel disease (IBD) at higher risk of relapse, a major study appearing in ...